- Conducting commercialization strategy consulting for technology-special listing (IPO) of companies in pharmaceuticals, biotechnology, medical devices, digital healthcare, AI, and materials/components.
(Served as a reviewer for the technology evaluation of technology-special listing (IPO) on KOSDAQ for pharmaceuticals, biotechnology, medical devices, digital healthcare, AI, and materials/components companies at the Korea Health Industry Development Institute, Jul 2018-Jun 2021)

- Contact: blessbyun@gmail.com